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Effect of monoclonal anti-ANP antibodies on the acute functional
adaptation to unilateral nephrectomy. The role of endogenous atrial
natriuretic peptide (AMP) in the immediate response of sodium excre-
tion to unilateral nephrectomy (UNX) was investigated in anesthetized
euvolemic rats through measurement of UNX-induced change in
plasma ANP concentration and the response of the remaining kidney to
UNX following administration of monoclonal anti-ANP antibodies. The
circulating ANP levels almost tripled (from 23 4 to 66 13 fmol/ml,
P < 0.01) within two minutes after UNX, whereas no change resulted
from sham intervention. In the control group receiving vehicle injec-
tion, UNX resulted in a twofold increase in urinary sodium excretion
(from 1.39 0.25 to 2.88 0.28 jsmollmin, P < 0.01) related to a
decrease in the fractional reabsorption of sodium at both proximal and
distal sites (estimated from fractional excretion of lithium). Urinary
excretion of cyclic guanosine 3'-5'-monophosphate (cGMP) increased
as well, but glomerular filtration rate did not change. In addition, UNX
was associated with a short-lived (<20 mm) rise in systemic arterial
pressure and a transient fall in right atrial pressure. Administration of
monoclonal anti-AMP antibodies totally prevented the UNX-associated
natriuresis by blunting both proximal and distal tubular reabsorption of
sodium, and suppressed the rise in urinary cGMP excretion following
UNX. The duration of the post-UNX increase in arterial pressure was
longer when compared to values observed in controls. These observa-
tions indicate that ANP release is stimulated after uninephrectomy.
UNX-induced changes in arterial pressure and electrolyte excretion are
altered by administration of anti-ANP antibodies, thus suggesting that
ANP may be an important mediator of the acute adaptation to unilateral
renal ablation.
The immediate response of the remnant kidney to unilateral
nephrectomy (UNX) is characterized by a consistent increase
in sodium excretion in the presence of no significant alteration
in glomerular filtration rate, renal hemodynamics, blood volume
or blood composition and a mild decrease in cardiac output [1].
Based on studies conducted iii dogs, it was proposed that the
increase in arterial pressure that occurred immediately after
UNX and subsided within 15 minutes could play a role in
initiating this response. Post-UNX natriuresis was blunted after
deactivation of barorellex mechanisms by m.ans of bilateral
surgical denervation of carotid sinus, clamping of common
carotid arteries, or pump perfusion of the common carotid
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circulation at constant pressure [I]. In studies conducted in
anesthetized rats it was demonstrated that acute surgical
destruction of renal nerves [21 and blockade of opiate receptors
by naloxone or prior induction of tolerance to morphine [3] also
reduced the immediate natriuretic response to UNX. Post-
UNX natriuresis was also shown to be associated with the
pituitary release of a peptide derived from proopiomelanocortin
[41.
The physiological importance of atrial natriuretic peptide
(ANP), a substance primarily secreted by cardiac atria and
potentially implicated in the short-term regulation of extracel-
lular fluid volume and arterial pressure, is still debated [5, 6]. In
recent years, a monoclonal anti-ANP antibody has been pro-
duced that specifically blocked the effects of both exogenously
administered and endogenously released ANP [7—9]. Adminis-
tration of such monoclonal antibodies resulted in a consistent
blunting of the natriuretic response [8] as well as the increase in
urinary cGMP excretion [101 and decrease in plasma renin
activity [111 associated with acute volume expansion. In the
present studies, the same monoclonal anti-ANP antibodies [8,
10, 11] were used to assess the role of endogenous ANP in the
immediate response to UNX. These experiments were
prompted by our recent observation that the natriuretic re-
sponse to UNX was blunted by prior removal of the right atrial
appendage, a major source of circulating ANP [121.
Methods
Studies were conducted in male Sprague-Dawley rats
(Charles-River, France) weighing 225 to 375 g and allowed free
access to food and water. On the day of experiments, rats were
anesthetized with mactin (100 mg/kg i.p., Byk-Gulden, Ger-
many) and placed on a temperature-regulated table (rectal
temperature maintained at 37 0.5°C). Animals were tracheos-
tomized to allow spontaneous breathing and prepared for acute
experimentation as previously described [121. Briefly, catheters
were inserted into a femoral artery, a femoral vein, a carotid
artery and the right jugular vein for blood sampling, solutes
administration and continuous measurement of systemic arte-
rial and right atrial pressures (Statham P50 pressure transducers
connected to a Gould recorder), respectively. A PE-60 catheter
was inserted into the dome of the urinary bladder via a midline
suprapubic incision for urine collections. During the surgical
preparation, a solution containing 3% bovine serum albumin
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Group Ia
Sham
Group lb
UNX P
Number 8 11
Body weight g 335 4 337 9 NS
Mean arterial pressure mm Hg 113 7 116 4 NS
Heart rate beats/mm 322 14 336 14 NS
Hematocrit % 42.5 0.7 41.9 0.8 NS
Plasma protein concentration 5.35 0.15 5.38 0.14 NS
g/dl
Urine flow pJ/min 8.3 0.9 8.7 1.4 NS
Sodium excretion pinol/min 0.92 0.29 0.90 0.39 NS
Potassium excretion ismol/min 0.97 0.24 1.02 0.13 NS
Plasma ANP concentration 23.5 3.6 22.2 4.1 NS
fmol/ml
(Sigma Chemical, St. Louis, Missouri, USA) in saline was
infused to replace fluid losses up to a total volume of 1.25% of
body weight. After completion of surgery, albumin infusion was
discontinued and replaced by a solution of 0.9% sodium chlo-
ride infused at a rate of 40 tl/min throughout the remainder of
experiments. Two series of experiments were performed.
Experiment 1: Effect of UNX on plasma immunoreactive
ANP concentration
Following surgical preparation and stabilization of arterial
pressure and urine flow, 2.5 ml of arterial blood was drawn and
rapidly transferred into ice-cold tubes containing the following
proteases inhibitors: 1 mg EDTA (Merck, Darmstadt, Germa-
ny), 500 KIU (Kallikrein inactivator units) aprotinin (Rhóne
Poulenc, Pal-is, France), 10 g pepstatin A and 100 g phenyl-
methylsulfonyl fluoride (Sigma) per ml of blood. Blood was
immediately centrifuged (3,000 rpm) at 4°C for 15 minutes, and
plasma was kept frozen at —80°C until subsequently extracted
and analyzed for immunoreactive ANP (ir-ANP). The sampled
blood was replaced by an equal volume of whole blood freshly
harvested from a donor rat.
After a 30-minute additional equilibration period, three to
four urine collections of 20 minutes each were obtained in
weighed plastic vials under water-equilibrated mineral oil.
Urine volume was determined from urine weight and specific
gravity measured with an eye-piece refractometer (Atago, Ja-
pan). At the end of the last urine collection, the right kidney was
exposed using a dorsal approach and either removed (group Ib,
UNX, N = 11) or gently manipulated and left in place (group Ia,
sham, N = 8). A second arterial blood sample was obtained two
minutes after UNX or sham UNX prior to sacrifice of animals.
Experiment 2: Effect of monoclonal anti-ANP antibodies on
the acute response to UNX
To assess the role of a change in ANP in post-UNX natriure-
sis, a second series of experiments was conducted in which
renal ablation was performed in rats pretreated by monoclonal
anti-ANP antibodies. Preparation and production, as well as the
efficacy of these monoclonal anti-ANP antibodies have been
described previously [8, 10, 11]. Briefly, atriopeptin II was
coupled to keyhole limpet hemocyanin and injected to female
BALB/c mice. Spleen cells from immunized mice were fused
with mouse myeloma cell line X63-Ag8.653 in the presence of
polyethylene glycol. Supernatant from all wells showing cell
growth after the selection procedure was screened for anti-
atriopeptin antibodies. Hybridoma cells from wells containing
such antibodies were cloned twice, then cloned cells were used
for production of ascitic fluid in male BALB/c mice. Blank
ascitic fluid raised in the same strain was used as control.
Rats were prepared as described above, except that lithium
chloride (0.5 mmol/kg) was given by gavage 90 minutes prior to
anesthesia, and radioactive tracers used for clearance studies
were added to 0.9% saline after completion of the surgery.
Following a 45-minute equilibration period, three to four urine
collections of 20 minutes each were obtained (control period).
At the midpoint of each clearance period, a blood sample was
drawn. After centrifugation, plasma was saved and stored for
future analysis; red blood cells were resuspended in an equal
volume of normal saline and injected back to the animal via the
femoral vein. At the end of the control period, rats received
either control ascitic fluid (group II, N = 20) or monoclonal
anti-ANP antibodies (group III, N = 18). The right kidney was
then removed in one-half of each group (JIb, N = 12 and IIIb,
N = 10), whereas sham intervention was performed in the
remaining animals (ha, N = 8 and lila, N 8). Thereafter,
20-minute urine collections were obtained during the 20 to 120
minute period following UNX or sham intervention (experimen-
tal period).
To avoid infusion of a large volume and to maintain a
circulating level of antibodies sufficient to block the effects of
ANP for the duration of experiments, the preparation of mono-
clonal anti-ANP antibodies (titer 1:1,600,000), or a similar
volume of control ascitic fluid, were given thrice as an i.v. bolus
injection of 70 j.d each (5 mm prior to, and 40 and 80 minutes
following UNX or sham intervention).
Table 1. Baseline values for systemic parameters, renal excretory
function and plasma ANP concentration in sham experiments and
UNX
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Fig. 1. Plasma concentration of immunoreactive atrial natriuretic pep-
tide at baseline (striped bars) and two minutes after (filled bars)
unilateral nephrectomy (UNX) or sham intervention. *P < 0.01; NS,
not significant.
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Table 2. Effect of unilateral nephrectomy or sham operation on systemic hemodynamics, glomerular filtration rate, hematocrit, and plasma
protein concentration
MAP mm Hg HR beats/mm GFR ml!
CTL EXP CTL EXP CTL
mm
EXP
He
CTL
matocrit %
EXP CTL
PPC gidi
EXP
Group Ha: Nonspecific antibodies, sham nephrectomy (N = 8)
111 106 392 381 1.11 0,94 43.0 42.6 5.4 4.9
±2 ±3 ±5 ±8 ±0.07 ±0.07 ±0.3 ±0.3 ±0.1 ±0.1
NS NS NS NS a
Group Jib: Nonspecific antibodies, unilateral nephrectomy (N = 12)
110 106 360 357 0.98 1.00 47.7 45.9 5.3 4.9
±5 ±4 ±10 ±8 ±0.08 ±0.07 ±0.4 ±0.3 ±0.1 ±0.1
NS NS NS NS a
Group lila: Monoclonal anti-ANP antibodies, sham nephrectomy (N = 8)
118 121 333 327 1.05 0.92 43.7 42.1 5.2 4.9
±6 ±7 ±14 ±15 ±0.11 ±0.08 ±1.0 ±1.4 ±0.0 ±0.1
NS NS NS NS a
Group Ilib: Monoclonal anti-ANP antibodies, unilateral nephrectomy (N = 10)
102 104 320 317 1.01 0.92 46.2 45.0 5.2 4.8
±4 ±4 ±6 ±6 ±0.05 ±0.07 ±0.9 ±1.0 ±0.1 ±0.1
NS NS a NS a
Values are means ± SEM of multiple observations during control period (CTL) and after the experimental maneuver (EXP) for either sham
nephrectomy or unilateral nephrectomy, Abbreviations are: MAP, mean arterial pressure; HR, heart rate; GFR, glomerular filtration rate; PPC,
plasma protein concentration; NS, not significant.
a P < 0.05 vs. control period.
Table 3. Effect of unilateral nephrectomy or sham operation on single kidney electrolyte excretion
UV UNaV FENa FELl
pd/mm junol/min %
CTL EXP CTL EXP CTL EXP CTL EXP
F
CTL
DRN
%
a
EXP
uv
pinolim
CTL
in
EXP CTL
FEK
%
EXP
Group ha: Nonspecific antibodies, sham nephrectomy (N = 8)
10.9 9.2 1.21 1.14 0.71 0.71 28.7 27.6 97.4 97.4 1.66 1.65 32.3 33.0
±0.6 ±0.5 ±0.06 ±0.08 ±0.05 ±0.06 ±1.2 ±1.4 ±0.1 ±0.1 ±0.05 ±0.05 ±1.6 ±1.3
NS NS NS NS NS NS NS
Group lib: Nonspecific antibodies, unilateral nephrectomy (N = 12)
17.5 17.6 1.39 2.88 1.06 2.18 25.6 32.5 95.5 92.7 1.12 2.21 25.9 48.1
±4.3 ±2.5 ±0.30 ±0.30 ±0.20 ±0.28 ±2.6 ±3.9 ±0.9 ±1.0 ±0.14 ±0.23 ±3.8 ±6.0
NS a a a a a a
Group lila: Monoclonal anti-ANP antibodies, sham nephrectomy (N = 8)
17.1 15.3 1.72 1.74 0.87 0.96 28.6 27.6 98.5 98,2 1.69 1.50 25.9 26.7
±2.3 ±2.9 ±0.30 ±0.30 ±0.13 ±0.13 ±2.5 ±2.7 ±0.2 ±0.3 ±0.27 ±0.24 ±2.5 ±3.5
NS NS NS NS NS NS NS
Group hhib: Monoclonal anti-ANP antibodies, unilateral nephrectomy (N = 10)
16.2 12.6 1.74 1.75 1.32 1.39 25.3 23.2 95.1 94.2 1.35 1.53 30.6 36.8
±2.7 ±2.0 ±0.29 ±0.37 ±0.21 ±0.27 ±1.3 ±2.1 ±0.7 ±1.2 ±0.19 ±0.19 ±4.5 ±3.7
NS NS NS NS NS NS NS
Values are means ± SEM of multiple observations during control period (CTL) and after the experimental maneuver (EXP) for either sham
nephrectomy or unilateral nephrectomy. UV, urine flow; UNaV, UKV, urinary excretion of sodium and potassium; FENa, FELl, FEK, fractional
excretion of sodium, lithium and potassium; FDRNa, fractional distal reabsorption of sodium; NS, not significant.
a P < 0.02 vs. control period
Analytical techniques and statistical evaluation
Analytical methods used in this laboratory were previously
detailed [12]. Briefly, hematocrit (Hct) was determined in
triplicate on each blood sample by spinning blood at 12,000 rpm
in a microfuge. Plasma protein concentration was measured by
refractometry. Plasma and urine sodium and potassium concen-
trations were determined by flame photometry. Lithium in
plasma and urine was determined by atomic absorption spec-
trophotometry. Glomerular filtration rate (GFR) was estimated
by the clearance of 99mTc.4iethylefletriiflepentaacetic acid
(DTPA). Clearances of sodium (CNa) and potassium (CK) were
calculated by standard formulas, and fractional excretions of
Na and K were calculated as (CNa/GFR) x 100 and (CK/GFR)
x 100, respectively. The fractional excretion of lithium (CL11
GFR) x 100 was used as an index of whole kidney proximal
tubular reabsorption [13]. Fractional distal reabsorption of
sodium was calculated as [1 — (CNa/CLI)] x 100.
Plasma concentration of ir-ANP was determined by radioim-
munoassay as previously described [14]. Briefly, after solid-
phase extraction of plasma on Bondelut cartridges (Analyt-
ichem International, Harbor City, California, USA), ANP
immunoreactivity was measured using an antiserum raised in
New Zealand rabbits. Following the extraction procedure, the
recovery of added ANP was 93 to 104%. The limit sensitivity of
the assay was 1.1 fmol/ml. The inter- and intraassay coefficients
of variation were 11% and 7%, respectively. In addition, urine
samples were directly analyzed for cGMP material after dilution
with tris-EDTA buffer, using a commercially available radioim-
munoassay (Amersham, France).
Since in previous experiments, no difference in renal function
between the right and left kidney, as estimated by separate
ureteral catheterization, was observed [3], basal values were
expressed for a single kidney by halving the total kidney
function. Results of all clearance determinations were averaged
to provide a single value for control and experimental periods in
each rat. Data are expressed as mean SEM. Two-way analysis
of variance and Student's i-test with correction for multiple
comparison when indicated were used to assess significance
within and between groups. A P value of 0.05 was considered
the minimum level of significance.
Results
Experiment 1: Effect of UNX on plasma concentration of
immunoreactive ANP
As shown in Table 1, baseline (that is, measured during the
hour preceding the experimental maneuver) mean values of
ha lib
Sham UNX
non-specific ascitic fluid
systemic parameters and renal excretory function were similar
in sham (group Ia) and UNX rats (group Ib) and not different
from those observed in groups II and III (vide infra). When data
from both groups were pooled, no correlation between basal
ir-ANP concentration and basal natriuresis was observed.
Within two minutes after UNX, plasma concentration of
ir-ANP increased by 42.8 12.8 fmollml (P <0.01) from a basal
value of 22.2 4.1 fmol/ml, whereas no significant change
occurred in the sham-operated animals (Fig. 1).
Experiment 2: Effect of monoclonal anti-ANP antibodies on
the response to UNX
As summarized in Table 2, values for systemic as well as
renal parameters were not different between groups during the
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Fig. 2. Early change in mean arterial pressure (MAP) and right atrial
pressure (RAP) after unilateral nephrectomy (UNX) in rats receiving
the nonspecific ascitic fluid (filled circles) or monoclonal anti-ANP
antibodies (open circles). § P < 0.05 between groups.
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Fig. 3. Individual changes in urinary excretion of sodium (A) and
potassium (B) in response to sham intervention (triangles) or unilateral
nephrec:omy (circles) in rats receiving nonspecjflc ascitic fluid (filled
symbols) or monoclonal anti-ANP antibodies (open symbols), Values
are given for one kidney; * P < 0.005 post-UNX vs. basal values.
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Fig. 4. Urinary excretion of cGMP at baseline (open bars) and in
response to acute unilateral nephrectomy (filled bars) in rats receiving
nonspecjfic ascitic fluid or monoclonal anti-A NP antibodies and under.
going sham intervention or UNX. * P < 0.01 post-UNX vs. basal
values.
basal period and remained stable with time in the two groups of
rats undergoing sham nephrectomy.
As depicted in Figure 2, mean arterial pressure (MAP)
increased immediately (+ 13.5 1.4% at 4 mm post-UNX, P <
0.0001), and progressively (within 25 mm) returned to pre-UNX
values in rats given the nonspecific fluid (group JIb). In rats
pretreated with monoclonal anti-ANP antibodies (group Ilib),
UNX was associated with an immediate increase in MAP
(+11.2 2.1% at 4 mm, P < 0.0001) of similar magnitude.
However, MAP remained elevated for the following 40 minutes,
prior to returning to baseline. At 60 minutes post-UNX, MAP
was not significantly different between these two groups. Also
shown in Figure 2 is the evolution of right atrial pressure (RAP)
in both groups: in fact, post-UNX RAP did not differ signifi-
cantly from basal values except for a prompt (within 1 mm) and
transient (4 mm duration) decrease. The magnitude of this
immediate UNX-induced fall in RAP was similar in both
groups. Neither MAP nor RAP was affected by sham nephrec-
tomy in the presence of either vehicle (group ha) or monoclonal
anti-ANP antibodies (group lila).
In rats receiving control ascitic fluid, UNX was associated
with a natriuretic and kaliuretic response of the remaining
kidney (+ 194 62 and + 120 26% respectively, both P <
0.005) and no measurable change in GFR (Tables 2 and 3). In
this group (lib), a significant increase in lithium clearance and
fractional excretion of lithium as well as a significant decrease
in the fractional distal reabsorption of sodium were observed
following UNX. As shown in Figure 3, administration of
monoclonal anti-ANP antibodies totally prevented the natri-
uretic and kaliuretic response to UNX (group IlIb: —4.8 9.4%
and +30.2 26.2%, respectively, both P = NS). Anti-ANP
antibodies had no effect on sodium and potassium excretion per
se (group lIla: +4.4 13.2% and +0.3 14%, respectively). In
addition, in rats pretreated by monoclonal anti-ANP antibodies,
a slight decrease in GFR occurred in response to both UNX (P
< 0.05) and sham intervention (where it failed to reach statis-
tical significance). No change in fractional excretion of lithium
or fractional distal reabsorption of sodium was observed fol-
lowing UNX in rats pretreated by anti-ANP antibodies.
As shown in Figure 4, urinary excretion of cGMP almost
doubled in response to UNX in rats treated by control ascitic
fluid (group lib). Administration of monoclonal anti-ANP anti-
bodies entirely blocked the urinary cGMP response to UNX
(group IlIb) whereas antibodies had no effect by themselves on
urinary excretion of cGMP (group lila). When data obtained in
groups II and III were pooled, a positive correlation between
UNX-associated changes in urinary excretion of sodium and
cGMP was observed (r 0.83, P < 0.001).
Discussion
The present results indicate that UNX, which is known to
result in a prompt increase in the urinary excretion of sodium by
the remaining kidney, was associated with a consistent and
almost immediate increase in the circulating level of ANP.
Administration of monoclonal antibodies that specifically block
the in vivo effects of circulating ANP [8, 10, 11] actually
prevented this natriuretic response as well as the increase in
fractional excretion of lithium and potassium and the rise in
urinary cGMP associated with UNX. In addition, a sustained
post-UNX increase in arterial pressure was observed in rats
given anti-ANP antibodies when compared to the transient
response observed in controls. These observations suggest that
ANP may be an important mediator in the immediate natriuretic
response of the kidney to controlateral nephrectomy as well as
a counterregulatory mechanism attenuating the concomitant
rise in arterial pressure.
In response to UNX, circulating levels of ANP rose by
threefold within two minutes, a change which cannot be ex-
plained on the sole basis of the suppression of ANP epuration
by one kidney through clearance receptors and atnopeptidase
action [15, 161. Of interest, it was previously shown that the
UNX-induced rise in circulating ANP may still be detectable
two hours after UNX [12].
Whether a threefold increase in circulating ANP levels will
account for a twofold increase in urinary sodium excretion may
be a matter of debate [5, 6]. Presumably due to differences in
experimental conditions, various changes in sodium excretion
relative to changes in ANP were reported in rats submitted to
volume expansion [10, 17, 18]. In anesthetized euvolemic rats,
a low-dose infusion of ANP resulting approximately in a dou-
bling of circulating ir-ANP was associated with a 2.3-fold
increase in urinary sodium excretion [19]. In awake rats,
natriuresis as well as urinary cGMP correlated in a time-
dependent and concentration-dependent fashion with exoge-
nously administered ANP [20]. To establish a causal relation-
ship between changes in ANP and post-UNX natriuresis, it was
logical to assess the effect of suppression of ANP action or
prevention of ANP changes. In a previous study, it was
observed that right atrial appendectomy suppressed the natn-
uretic and cyclic GMP responses of the remaining kidney as
well as the rise in circulating ANP induced by contralateral
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nephrectomy [12]. In the present studies, the use of a mono-
clonal antibody raised against ANP totally prevented the im-
mediate post-UNX natriuresis.
The administration of anti-ANP antibodies was shown to
blunt the natriuretic response [8, 9, 211 as well as the increase in
the plasma level, renal content and urinary excretion of cyclic
GMP [10] and the decrease in plasma renin activity [11]
associated with acute hypervolemia. In addition, in anesthe-
tized normal [22, 23] and spontaneously hypertensive rats [24],
a mild rise in arterial pressure and cardiac output and a transient
decrease in urinary sodium excretion were observed in re-
sponse to anti-ANP antibodies. Moreover, anti-ANP antibodies
resulted in a decrease in urinary sodium excretion in rats with
congestive heart failure induced by myocardial infarction [25].
In addition, anti-ANP antibodies were shown to attenuate the
degree of hyperfiltration found in rats with streptozotocin-
induced diabetes mellitus [261.
Administration of anti-ANP antibodies resulted in a slight
decrease in glomerular filtration rate, which reached statistical
significance in the UNX group but not in sham-operated rats.
Although such a change could account in part for the decrease
in urinary sodium excretion, it must be noted that the post-
UNX increase in the fractional excretion of sodium was totally
suppressed by anti-ANP antibodies. Because most investiga-
tors observed an absence of early change in glomerular filtration
rate [1, 12, 27], it is accepted that the natriuretic response to
contralateral nephrectomy results primarily from a decrease in
tubular reabsorption of sodium. Based on micropuncture stud-
ies [28] and in accordance with studies using the lithium
clearance method [12], it is postulated that both proximal and
distal parts of the nephron contribute to the natriuretic response
to UNX.
In addition to a direct renal effect, ANP might have modu-
lated the systemic hemodynamic changes associated with
UNX. In the dog, UNX is followed by a transient rise in blood
pressure and a decrease in cardiac output and venous return
[29]. Similarly to observations made with atrial appendectomy
[12], administration of monoclonal anti-ANP antibodies re-
sulted in an increas: in the duration (but not the magnitude) of
the blood pressure rise associated with UNX. Thus, the in-
crease in circulating ANP may attenuate the immediate pressor
response to UNX.
Interestingly, the post-UNX rise in plaso,t ANP levels was
associated with a decrease in right atrial pr ssure (Fig. 3), and
presumably right atrial distension, which is thought to be the
major stimulus for ANP release in the presence of acute volume
expansion [18]. Moreover, previous experiments indicated that
right appendectomy prevented the post-UNX increase in both
sodium excretion and circulating ANP [12]. Although it cannot
be excluded that, in the present experiments, ANP release
might result from the acute post-UNX rise in arterial blood
pressure via left atrial stretch, we could speculate that other
ANP stimulating factors might have been implicated, such as
the sympathetic nervous system and/or humoral substances
(that is, angioter'in II, catecholamines, vasopressin, endothe-
lin, endogenous opioids). Conceivably, activation of the
sinoaortic baroreceptor [30] or afferent renal nerves [311 may
contribute to a reflex stimulation of ANP release following
UNX. Alternatively, a pituitary control of ANP release was
suggested in experiments conducted in volume expanded-rats
[32, 331. The identification of the precise ANP-stimulating
factor involved in post-UNX natriuresis thus requires further
studies.
Taken together, the results of previous [12] and present
personal studies indicate that UNX is associated with a rapid
and sustained increase in plasma levels of ANP, and that
blockade of the effect of circulating ANP as well as prevention
of the UNX-induced rise in ANP abolish the natriuretic re-
sponse to contralateral nephrectomy. Atrial natriuretic peptide
thus plays a pivotal role in the acute adaptation to unilateral
nephrectomy.
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